You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MERTK

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MERTK Signalling in Monocytes/Macrophages in Liver Disease

Recruiting
  • Liver Disease
  • +3 more
  • blood sampling for research purpose
  • +3 more
  • Basel, Switzerland
  • +3 more
Nov 17, 2021

Retinal Disease, Retinitis Pigmentosa Trial in Riyadh (Subretinal administration of rAAV2-VMD2-hMERTKRecombinant

Completed
Has Results
  • Retinal Disease
  • Retinitis Pigmentosa
  • Subretinal administration of rAAV2-VMD2-hMERTKRecombinant Adeno-Associated Virus
  • Riyadh, Saudi Arabia
    King Khaled Eye Specialist Hospital
Jan 25, 2022

Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Lung Non-Small Cell Carcinoma
  • +4 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Mar 8, 2022

Combination of Leukocyte Cell Surface Biomarkers Measured by

Not yet recruiting
  • Bacterial and Viral Infections
  • 2 additional whole blood samples of 6mL each will be taken
  • (no location specified)
Nov 30, 2023

Advanced or Metastatic Solid Malignancies Trial in United States (Sitravatinib, Nivolumab, Pembrolizumab)

Enrolling by invitation
  • Advanced or Metastatic Solid Malignancies
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

Advanced Cancer, Metastatic Cancer, Tumors Trial in Atlanta, Chapel Hill (MRX-2843)

Recruiting
  • Advanced Cancer
  • +5 more
  • Atlanta, Georgia
  • +1 more
Mar 4, 2022

NSCLC, Solid Tumor Trial in Boston (Merestinib)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Solid Tumor
  • Boston, Massachusetts
  • +1 more
Jan 26, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia Trial in Atlanta, New York (MRX-2843)

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Atlanta, Georgia
  • +2 more
Jul 6, 2022

Clear-Cell Renal Cell Carcinoma Trial in Houston (Sitravatinib, Nivolumab, Ipilimumab)

Enrolling by invitation
  • Clear-Cell Renal Cell Carcinoma
  • Houston, Texas
    MD Anderson
Jan 23, 2022

Recurrent Endometrial Cancer, Solid Tumors Trial in Pittsburgh (pembrolizumab, Sitravatinib)

Recruiting
  • Recurrent Endometrial Cancer
  • Solid Tumors
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 12, 2022

Mer-TK in Human Cardiac Cells

Completed
  • Myocardial Inflammation
  • Myocardial Infarction
  • Change in Soluble MER Concentration
  • Chicago, Illinois
    Ann & Robert H Lurie Children's Hopsital
Aug 10, 2021

Advanced Biliary Tract Cancer Trial in Seoul (Sitravatinib, Tislelizumab)

Unknown status
  • Advanced Biliary Tract Cancer
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 23, 2021

Tumor Metastasis Trial in Worldwide (PF-07265807, Sasanlimab, Axitinib)

Recruiting
  • Neoplasm Metastasis
  • Fayetteville, Arkansas
  • +33 more
Aug 20, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Urothelial Carcinoma Ureter Trial in United States (Sitravatinib, Nivolumab,

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Tucson, Arizona
  • +33 more
May 21, 2021

Alzheimer Trial in Hangzhou (sulforaphane, Placebo)

Unknown status
  • Alzheimer Disease
  • sulforaphane
  • Placebo
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital,Zhejiang University School of Medicin
May 9, 2020